What have we learnt from the rosiglitazone saga?

被引：11

|

作者：

Montori, Victor M.

Shah, Nilay D.

机构：

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2011年 / 342卷

关键词：

TYPE-2 DIABETES TIME;

D O I：

10.1136/bmj.d1354

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页数：2

相关论文

共 50 条

[1] THE EVOLUTIONARY SAGA OF CORTICOSTEROID IN MYASTHENIA GRAVIS AND WHAT WE HAVE LEARNT FROM THIS ...
Bandyopadhyay, Sankar
[J]. NEUROLOGY, 2017, 88
[2] THE EVOLUTIONARY SAGA OF CORTICOSTEROID IN MYASTHENIA GRAVIS AND WHAT WE HAVE LEARNT FROM THIS ...
Bandyopadhyay, Sankar
[J]. NEUROLOGY, 2017, 88
[3] Lessons to be learnt from rosiglitazone saga
[J]. Reactions Weekly, 2007, 1168 (1) : 1 - 1
[4] What have we learnt from Vioxx?
Krumholz, Harlan
Ross, Joseph S.
Presler, Amos H.
Egilman, David S.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7585): : 120 - 123
[5] What Have We Learnt from 2020?
Roach, V.
[J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2021, 61 : 139 - 139
[6] What have we learnt from AIDS?
Pinching, AJ
[J]. JOURNAL OF CLINICAL PATHOLOGY, 1997, 50 (11) : 885 - 886
[7] What have we learnt from Covid?
Salter, Mark Steven
[J]. BJPSYCH BULLETIN, 2021, 45 (02): : 122 - 123
[8] What have we learnt from SARS?
Weiss, RA
McLean, AR
[J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2004, 359 (1447) : 1137 - 1140
[9] What Have We Learnt From Chernobyl? What Have We Still To Learn?
Thomas, G. A.
Tronko, M. D.
Tsyb, A. F.
Tuttle, R. M.
[J]. CLINICAL ONCOLOGY, 2011, 23 (04) : 229 - 233
[10] JUDICIARY DIALOGUES AND MULTI-LEVEL GOVERNANCE WHAT HAVE WE LEARNT FROM THE "FONTEVECCHIA SAGA"?
Blas Esteban, Patricio
[J]. EN LETRA, 2018, 5 (09): : 54 - 108

← 1 2 3 4 5 →